October 6, 2021 – The name Pfizer may now be synonymous with coronavirus vaccine, but the company has been around for a long time and produces many drugs. One of them is about to be withdrawn from the Croatian market, and as such, Croatian patients who usually take it should contact their GP.
As Poslovni Dnevnik writes, a well-known drug is being withdrawn from the market, the Croatian Medicines and Medical Devices Agency reported on Monday.
Two batches of the drug Champix, produced by the American pharmaceutical giant Pfizer, are in the process of being withdrawn. The drug is used to help adults quit smoking, and given the extent of the smoking problem here, Croatian patients who use the drug should call their family doctor to be informed of what to do to continue. their therapies.
“In the Republic of Croatia, there are no other batches of these medicines which are not affected by this, it is the same situation with other medicines which contain the active ingredient varenicline. Therefore, we ask all users of this medicine to contact their doctor. regarding continuing their therapy, ” the agency said.
As the Marketing Authorization Holder for Champix, Pfizer, in cooperation with the Agency, is withdrawing from the Croatian market, the following lots of the following dosage forms of this medicine should no longer be:
– batch 00023401 of Champix 1 mg film-coated tablets
– batch 00022025 of Champix 0.5 mg and 1 mg film-coated tablets (the pack to start this therapy).
“The withdrawal is made at the wholesale level. The withdrawal procedure is carried out due to the increased level of nitrosamine contaminants in the medicine compared to the acceptable intake levels prescribed in the European Union (EU). Based on the available data, there is currently no risk to patients taking this drug, ” the agency concluded.
To learn more, be sure to check out our dedicated lifestyle section.